Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma

BACKGROUND: The emergence of immune checkpoint inhibitors (ICIs) has significantly improved the clinical outcomes of patients with metastatic melanoma. However, survival benefits are only observed in a subset of patients. The fibroblast growth factor receptor (FGFR) family genes are frequently mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wengang, Xia, Handai, Yang, Rui, Zhang, Yuqing, Zheng, Qi, Shang, Xiaoling, Liu, Ni, Ma, Xinchun, Wei, Chenxi, Chen, Hang, Mu, Xin, Wang, Xiuwen, Liu, Yanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681151/
https://www.ncbi.nlm.nih.gov/pubmed/36426352
http://dx.doi.org/10.3389/fimmu.2022.1030969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681151/
https://www.ncbi.nlm.nih.gov/pubmed/36426352
http://dx.doi.org/10.3389/fimmu.2022.1030969

Ejemplares similares